Royce & Associates’s Korro Bio KRRO Stock Holding History

Royce & Associates’s Portfolio KRRO Stock Details KRRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-25	Closed	-$29K	–	1084
2020 Q2	$29K	Buy	+25	New	+$22.6K	﹤0.01%	1096

Other funds holding KRRO

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return

Mizuho Securities Tokyo, Japan $7.68M AUM 15.91% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Royce & Associates's KRRO Position: Q3 2020 in Review

Royce & Associates sold out of Korro Bio (KRRO) in Q3 2020, closing a stake of 25 shares — an estimated $29K sold.

Royce & Associates first reported a position in KRRO in Q2 2020 and held it in 1 quarter. The position peaked at $29K in Q2 2020. 71 funds tracked by Wall St. Rank hold KRRO as of Q3 2020.

Royce & Associates reported no remaining Korro Bio position as of Q3 2020 after selling out during the quarter.
Royce & Associates sold 25 Korro Bio shares in Q3 2020, an estimated $29K.
Royce & Associates first reported a position in Korro Bio in Q2 2020 and held it in 1 quarter.
Royce & Associates's Korro Bio position peaked at $29K in Q2 2020.
71 funds tracked by Wall St. Rank held Korro Bio as of Q3 2020.

Based on Royce & Associates's 13F filing for Q3 2020, filed 12 Nov 2020.